Experimental design
BLIND
The current investigation was a double-blind, crossover, randomized, placebo-controlled trial. To ensure that both researchers and participants were blind to the conditions, an independent pharmacist prepared and administered all supplements. Following two sessions of protocol familiarization, participants were randomly assigned to one of five conditions: CAF, NaHCOSchematics of experimental steps.